Vani Vannappagari

University of North Carolina at Chapel Hill

Also affiliated with Goethe University Frankfurt, ViiV Healthcare (Spain)

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.744Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency Virus

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1878

Top 27%

0.744DataRank

Top 27%22 citations

Lene Ryom, Bastian Neesgaard, Gilles Wandeler, Thérèse Staub, Martin Gisinger +68 more

Papers

Driven by 12 papers — median percentile 73. Top paper: “Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency Virus”.

Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency Virus

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1878

Top 27%

0.744DataRank

Top 27%22 citations

Lene Ryom, Bastian Neesgaard, Gilles Wandeler, Thérèse Staub, Martin Gisinger +68 more

Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium

The Lancet HIV(2021)10.1016/s2352-3018(21)00163-6

N/A

0DataRank · unranked

64 citations

Andrew Phillips, Cristiana Oprea, Katharina Grabmeier‐Pfistershammer, Huldrych F. Gunthard, Stéphane De Wit +36 more

Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study

Clinical Infectious Diseases(2023)10.1093/cid/ciad219

N/A

0DataRank · unranked

23 citations

Amanda Mocroft, Lene Ryom, Bastian Neesgaard, Simon Edwards, Veronica Svedhem +73 more

Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts

The Lancet HIV(2024)10.1016/s2352-3018(23)00328-4

N/A

0DataRank · unranked

48 citations

Mark N. Polizzotto, Fernando Maltêz, Andri Rauch, Katharina Grabmeier‐Pfistershammer, Ferdinand W.N.M. Wit +20 more

Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration

Clinical Infectious Diseases(2024)10.1093/cid/ciae228

N/A

0DataRank · unranked

29 citations

Lene Ryom, Annegret Pelchen–Matthews, Amanda Mocroft, Daniel Elbirt, Cristiana Oprea +91 more

Integrase Strand Transfer Inhibitor–Related Changes in Body Mass Index and Risk of Diabetes: A Prospective Study From the RESPOND Cohort Consortium

Clinical Infectious Diseases(2024)10.1093/cid/ciae406

N/A

0DataRank · unranked

28 citations

Loveleen Bansi‐Matharu, Matthew Law, Robert Zangerle, Andri Rauch, Philip Tarr +22 more

Factors associated with vertical transmission of HIV in the Western Cape, South Africa: a retrospective cohort analysis

Journal of the International AIDS Society(2024)10.1002/jia2.26235

N/A

0DataRank · unranked

13 citations

Emma Kalk, Alexa Heekes, Florence Phelanyane, Nisha Jacob, Andrew Boulle +7 more

Effectiveness of dolutegravir-based regimens compared to raltegravir-, elvitegravir-, bictegravir, and darunavir-based regimens among older adults with HIV in the Veterans Aging Cohort Study (VACS)

AIDS Research and Therapy(2024)10.1186/s12981-024-00681-w

N/A

0DataRank · unranked

4 citations

Cassidy Henegar, Vincent C. Marconi, Kirsha S. Gordon, Charles B. Hicks, Vani Vannappagari +3 more

Brief Report: Interest in Long-acting Injectable PrEP Among Transgender Women in Eastern and Southern United States

JAIDS Journal of Acquired Immune Deficiency Syndromes(2024)10.1097/qai.0000000000003465

N/A

0DataRank · unranked

6 citations

Sari L. Reisner, Tonia Poteat, Keri N. Althoff, Asa Radix, Megan Stevenson +11 more

Risk of Cancer in People With HIV Experiencing Varying Degrees of Immune Recovery With Sustained Virological Suppression on Antiretroviral Treatment for More Than 2 Years: An International, Multicenter, Observational Cohort

Clinical Infectious Diseases(2025)10.1093/cid/ciaf248

N/A

0DataRank · unranked

9 citations

Lene Ryom, Caroline Sabin, Lauren Greenberg, Matthias Cavassini, Alexander Egle +22 more

Preference for Long-Acting Injectable PrEP Compared With Daily Oral PrEP Among Transgender Women in the U.S.: Findings From a Multisite Cohort

AJPM Focus(2025)10.1016/j.focus.2025.100313

N/A

0DataRank · unranked

6 citations

Sari L. Reisner, Tonia Poteat, Asa Radix, Kenneth H. Mayer, Chris Beyrer +10 more

Mother‐child dyads living with HIV in the Western Cape, South Africa: Undetectable = Undetectable?

Journal of the International AIDS Society(2025)10.1002/jia2.26418

N/A

0DataRank · unranked

1 citations

Helena Rabie, Brian Eley, Lisa Frigati, James Nuttall, Emma Kalk +8 more

Vani Vannappagari

Indexed papers

Top data-sharing exemplar

Papers